HER2-POSITIVE STATUS

Clinical trials for HER2-POSITIVE STATUS explained in plain language.

Never miss a new study

Get alerted when new HER2-POSITIVE STATUS trials appear

Sign up with your email to follow new studies for HER2-POSITIVE STATUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Double attack on deadly pancreatic cancer shows promise

Disease control Ongoing

This study is testing whether adding a new antibody called HLX22 to an existing treatment (trastuzumab plus chemotherapy) works better for people with a specific type of advanced pancreatic cancer (HER2-positive). It aims to see if this combination can shrink tumors and help pati…

Matched conditions: HER2-POSITIVE STATUS

Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

HER2-POSITIVE STATUS

Get alerted when new HER2-POSITIVE STATUS trials appear

Double attack on deadly pancreatic cancer shows promise